Home › Research › Down syndrome and Alzheimer's
Down syndrome with Alzheimer's disease brains have increased iron and associated lipid peroxidation consistent with ferroptosis
Max Andrew Thorwald, José Arquimides Godoy-Lugo, Marc Vermulst, Henry Jay Forman, Elizabeth Head, Caleb E. Finch. Alzheimer s & Dementia, 2025-12-01
Topic: Brain proteins, microglia and lab models
Plain-language summary
Iron was 2-fold higher in DSAD. Iron storage proteins and lipid peroxidation were increased in prefrontal cortex, but not in the cerebellum. The glutathione synthesis protein GCLM was decreased by 50% in both AD and DSAD. Activity of lipid raft GPx4, responsible for membrane repair, was decreased by at least 30% in AD and DSAD. These decreases in GPx4 activity were paralleled by reduced α-secretase activity while β-secretase activity increased. DSAD shows greater lipid peroxidation than AD consistent with greater MBs and iron load. DSAD also shares similar and more pronounced features of AD such as decreased protein levels of critical GSH producing enzyme GCLM and other protective mechanisms against lipid peroxidation. The extensive increase of iron and lipid peroxidation suggests their linkage to APP gene dosage. The impairment of these key mechanisms asserts ferroptosis as a key feature during AD.
What this study adds
Evidence grade: Low
Brains of people with Down syndrome and Alzheimer's disease showed higher iron levels and signs of a cell death process called ferroptosis, with greater lipid damage than in Alzheimer's alone. Reported effect size: decreased by 50%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Thorwald, M. A., Godoy-Lugo, J. A., Vermulst, M., Forman, H. J., Head, E., & Finch, C. E. (2025). Down syndrome with Alzheimer's disease brains have increased iron and associated lipid peroxidation consistent with ferroptosis. Alzheimer s & Dementia. https://doi.org/10.1002/alz70855_105930
Vancouver
Thorwald MA, Godoy-Lugo JA, Vermulst M, Forman HJ, Head E, Finch CE. Down syndrome with Alzheimer's disease brains have increased iron and associated lipid peroxidation consistent with ferroptosis. Alzheimer s & Dementia. 2025. doi:10.1002/alz70855_105930. PMID: 41444200.
BibTeX
@article{thorwald2025-41444200,
author = {Thorwald, Max Andrew and Godoy-Lugo, José Arquimides and Vermulst, Marc and Forman, Henry Jay and Head, Elizabeth and Finch, Caleb E.},
title = {{Down syndrome with Alzheimer's disease brains have increased iron and associated lipid peroxidation consistent with ferroptosis}},
journal = {Alzheimer s \& Dementia},
year = {2025},
doi = {10.1002/alz70855_105930},
pmid = {41444200},
url = {https://doi.org/10.1002/alz70855_105930}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Iron storage proteins and lipid peroxidation were increased in prefrontal cortex, but not in the cerebellum.
- The glutathione synthesis protein GCLM was decreased by 50% in both AD and DSAD.
- Activity of lipid raft GPx4, responsible for membrane repair, was decreased by at least 30% in AD and DSAD.
- These decreases in GPx4 activity were paralleled by reduced α-secretase activity while β-secretase activity increased.
- DSAD shows greater lipid peroxidation than AD consistent with greater MBs and iron load.
Why it matters
Brains of people with Down syndrome and Alzheimer's disease showed higher iron levels and signs of a cell death process called ferroptosis, with greater lipid damage than in Alzheimer's alone. These findings suggest that targeting iron and lipid damage might be a future treatment approach, but this is early brain tissue research.
Study details
- Effect sizedecreased by 50%
- Evidence strengthLow
How this study scored 45/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia) |
| Journal's citation record | 2 / 4 | Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 11 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 3.7 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 3 / 6 | Cited 6.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 1 / 4 | Cited 11 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Caleb E. Finch: h-index 98 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University of Southern California: institution h-index 1,521 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 3 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41444200) |
| Free to read | 2 / 2 | Free to read |
| Total | 45 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1002/alz70855_105930
- PubMed: 41444200
- Original source →
- Free full text: Alzheimer s & Dementia →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in Down syndrome and Alzheimer's from nearby years
Also tagged “down”
527 studies in the library carry the topic tag “down”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 527 tagged studies.